Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
11 April 2016 |
Main ID: |
NCT02720250 |
Date of registration:
|
22/03/2016 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Omega-3 Fatty Acids Enriched Food and Microvascular Reactivity
|
Scientific title:
|
Effect of Omega-3 Fatty Acids Enriched Chicken Eggs Consumption on Microvascular Reactivity and Lipid Profile in Young Healthy Subjects |
Date of first enrolment:
|
March 2016 |
Target sample size:
|
50 |
Recruitment status: |
Recruiting |
URL:
|
https://clinicaltrials.gov/show/NCT02720250 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator)
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Croatia
| | | | | | | |
Contacts
|
Name:
|
Ana Stupin, MD, PhD |
Address:
|
|
Telephone:
|
+385915134958 |
Email:
|
anacavka@mefos.hr |
Affiliation:
|
|
|
Name:
|
Ana Stupin, MD, PhD |
Address:
|
|
Telephone:
|
'385915134598 |
Email:
|
anacavka@mefos.hr |
Affiliation:
|
|
|
Name:
|
Ines Drenjancevic, MD, PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Faculty of Medicine, University of Osijek, Croatia |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- healthy volunteers
Exclusion Criteria:
- oral contraceptives
- drugs that could affect endothelium
- hypertension
- coronary artery disease
- diabetes
- hyperlipidaemia
- renal impairment
- cerebrovascular and peripheral artery disease
Age minimum:
18 Years
Age maximum:
35 Years
Gender:
Both
|
Health Condition(s) or Problem(s) studied
|
Omega-3 Polyunsaturated Fatty Acids
|
Intervention(s)
|
Dietary Supplement: Regular chicken eggs
|
Dietary Supplement: Omega-3 chicken eggs
|
Primary Outcome(s)
|
microvascular reactivity
[Time Frame: Three weeks]
|
Secondary Outcome(s)
|
lipid profile
[Time Frame: Three weeks]
|
Secondary ID(s)
|
2158610714114
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|